Literature DB >> 3377943

Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients.

D J Duthie1, D J Rowbotham, R Wyld, P D Henderson, W S Nimmo.   

Abstract

Plasma fentanyl concentrations were measured during and after transdermal fentanyl delivery in groups of patients undergoing general surgery. At 8 and 12 h, concentrations did not differ from those observed in a matched group of patients receiving fentanyl by i.v. infusion. At 24 h, concentrations were significantly lower in one of the transdermal groups. Plasma fentanyl clearance did not differ significantly between the groups. Plasma fentanyl concentrations decreased slowly after removal of the transdermal system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377943     DOI: 10.1093/bja/60.6.614

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  15 in total

1.  Anesthesia for the 21st century.

Authors:  T H Stanley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

Review 2.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 3.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

4.  ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders.

Authors:  Michael J Moss; Brandon J Warrick; Lewis S Nelson; Charles A McKay; Pierre-André Dubé; Sophie Gosselin; Robert B Palmer; Andrew I Stolbach
Journal:  J Med Toxicol       Date:  2017-08-25

5.  Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study.

Authors:  Motoo Nomura; Minoru Kamata; Hiroyuki Kojima; Kenji Hayashi; Masasuke Kozai; Satoshi Sawada
Journal:  Support Care Cancer       Date:  2010-06-13       Impact factor: 3.603

Review 6.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

7.  Transdermal fentanyl for the treatment of pain after major urological operations. A randomized double-blind comparison with placebo using intravenous patient-controlled analgesia.

Authors:  K A Lehmann; C Einnolf; H J Eberlein; R Nagel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Pharmacokinetic characterisation of transdermal delivery systems.

Authors:  B Berner; V A John
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

9.  [New modes of opioid administration.].

Authors:  H W Striebel; R Schwagmeier; N Boerger
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

10.  Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.